PCM
GMED icon

Parsifal Capital Management’s Globus Medical GMED Stock Holding History

Parsifal Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.4M Sell
387,117
-835,600
-68% -$75M 3.93% 14
2025
Q4 		$107M Buy
1,222,717
+118,385
+11% +$8.99M 8.76% 4
2025
Q3 		$63.2M Buy
1,104,332
+251,571
+30% +$14.5M 5.89% 8
2025
Q2 		$50.3M Buy
852,761
+106,939
+14% +$6.91M 4.26% 11
2025
Q1 		$54.6M Sell
745,822
-84,581
-10% -$6.99M 4.72% 9
2024
Q4 		$68.7M Sell
830,403
-520,150
-39% -$41M 5.73% 9
2024
Q3 		$96.6M Buy
1,350,553
+453,053
+50% +$32M 6.61% 9
2024
Q2 		$61.5M Buy
+897,500
New +$53.6M 4.44% 9

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parsifal Capital Management's GMED Position: Q1 2026 in Review

Parsifal Capital Management reduced its Globus Medical (GMED) stake by 68% in Q1 2026, selling an estimated $75M and leaving 387,117 shares worth $33.4M. The position accounts for 3.93% of the portfolio, ranked #14.

Parsifal Capital Management first reported a position in GMED in Q2 2024 and has held it in 8 quarters since. The position peaked at $107M in Q4 2025. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Parsifal Capital Management held 387,117 shares of Globus Medical worth $33.4M as of Q1 2026.
  • Parsifal Capital Management sold 835,600 Globus Medical shares in Q1 2026, an estimated $75M.
  • Globus Medical made up 3.93% of Parsifal Capital Management's portfolio in Q1 2026, its #14 holding.
  • Parsifal Capital Management first reported a position in Globus Medical in Q2 2024 and has held it in 8 quarters since.
  • Parsifal Capital Management's Globus Medical position peaked at $107M in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Parsifal Capital Management's 13F filing for Q1 2026, filed 15 May 2026.